To Evaluate the Efficacy and Safety of GT20029 Solution in the Treatment of Androgenetic Alopecia (AGA) in Chinese Adult Males

NCT06692465 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
180
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Suzhou Kintor Pharmaceutical Inc,

Collaborators